查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2093178

心臟瓣膜修復與置換器材市場－2026-2032年全球市場預測

Heart Valve Repair & Replacement Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心臟瓣膜修復和置換設備的市場規模將達到 127 億美元，複合年成長率為 8.43%。

主要市場統計數據
基準年 2025 72億美元
預計年份：2026年 78億美元
預測年份：2032年 127億美元
複合年成長率 (%) 8.43%

心臟瓣膜修復和置換裝置在現代瓣膜性心臟病治療中發揮核心作用，包括主動脈瓣狹窄、二尖瓣逆流、三尖瓣疾病和先天性瓣膜畸形。人口老化、結構性心臟疾病診斷數量的增加以及臨床治療向微創介入心臟病學的轉變，都推動了市場需求的成長。裝置類別包括機械瓣膜、生物瓣膜、經導管主動脈瓣置換系統、經導管二尖瓣和三尖瓣修復技術、環狀成形術環、腱索修復系統、瓣膜封堵器和輔助輸送平台。臨床決策越來越依賴多學科心臟團隊的指導，他們會評估解剖結構、手術風險、耐久性要求、抗凝血治療需求、生活品質目標以及長期再次介入的考慮因素。此外，不斷更新的指南也支持在特定患者群體中更廣泛地使用經導管手術，以及人們對終身瓣膜管理的日益關注，這些因素都對市場發展產生了影響。隨著醫院加強其結構性心臟疾病項目，競爭的重點正從器械植入轉向手術計劃、影像整合、操作人員培訓、術後後續觀察和以患者為中心的結果。

心臟瓣膜裝置領域的變革性變化

隨著治療途徑從傳統的開胸手術轉向導管介入、混合式和微創手術，心臟瓣膜修復和置換裝置的格局正在發生重大變化。經導管主動脈瓣置換術術（TAVR）已成為許多重度症狀性主動脈瓣狹窄患者的成熟治療選擇。同時，二尖瓣和三尖瓣介入治療也在不斷發展，這得益於裝置固定、瓣葉復位、瓣環重塑以及瓣中瓣（VIV）技術的改進。影像學是推動這項變革的核心要素，心臟超音波圖、電腦斷層掃描（CT）、透視和融合影像技術有助於評估患者是否適合接受手術、指導手術導航並降低併發症。另一個重要的變化是，在治療年輕和低風險患者時，越來越重視瓣膜的耐久性、血流動力學性能、血栓症預防和瓣週漏減少，因為長期療效對這些患者特別重要。監管審查、上市後證據要求以及真實世界臨床註冊研究正在改變產品開發方式，它們優先考慮安全性、臨床終點以及在不同醫療環境中的可重複性。同時，醫院正在重組其心臟醫療服務體系，建立專業化的心臟疾病團隊、精簡的溝通網路和標準化的診療路徑，以縮短從診斷到介入的延遲時間。

人工智慧對瓣膜治療的累積影響

人工智慧 (AI) 正在對心臟瓣膜修復和置換器械的整個生態系統產生累積影響，尤其是在診斷、手術規劃、工作流程最佳化和時間序列監測方面。 AI 驅動的影像工具可以幫助臨床醫生分割瓣膜解剖結構、量化鈣化程度、評估瓣環尺寸、評估逆流嚴重程度，並確定經導管手術的解剖適應性。預測分析可以透過整合超音波心臟檢查觀察、CT 測量數據、合併症、虛弱指標、實驗室檢查值和先前介入治療資訊來支持心臟超音波圖，從而最佳化手術風險分層。在手術過程中，AI 驅動的影像導引和自動化可以提高器械尺寸選擇、入路規劃和植入模擬的一致性。同時，人們正在探索利用數位孿生和計算模型來預測血流動力學結果和器械與組織的相互作用。介入治療後，互聯監測和演算法分析有助於識別心律不整、瓣膜功能障礙、血栓風險、心臟衰竭補償以及後續影像檢查的必要性。隨著人工智慧應用範圍的擴大，一些管治重點也逐漸顯現，包括檢驗臨床有效性、減少偏差、數據互通性、網路安全、可解釋性以及負責任地將其整合到以醫生主導的決策過程中。

全球心臟瓣膜裝置部署的關鍵區域性見解。

在亞太地區，人口老化、心臟影像技術的進步以及對三級循環系統醫療中心投入的增加，都推動了治療需求的成長。中國、日本、印度、韓國和澳洲在結構性心臟疾病治療的引入方面處於主導。北美在經導管瓣膜治療、多學科心臟護理團隊的建立、保險報銷體係以及真實世界數據（RWE）的生成方面仍然保持著高度領先地位，並專注於基於指南的治療和上市後安全性監測。在拉丁美洲，主要城市心臟中心的專業化程度不斷提高，取得了一定的進展，但由於保險結構、治療費用、專家資源以及公共醫療體系的能力等因素，患者獲得治療的機會存在差異。在歐洲，其優勢在於成熟的心血管臨床網路、完善的醫療設備法律規範體係以及在外科瓣膜置換術和導管介入治療方面的廣泛專業知識，儘管各國的報銷政策正在影響這些治療的引入時間。在中東，透過投資建設專科醫院、醫療旅遊中心和微創心血管治療能力，尤其是在高所得醫療體系中，先進的心臟護理正在加強。而在非洲，由於風濕性心臟疾病負擔沉重、許多地區缺乏心臟外科手術基礎設施、人員短缺以及依賴區域核心醫療機構進行複雜介入治療等因素，心臟瓣膜修復和置換設備的獲取仍然不均衡。

經濟和策略聯盟的關鍵群體分析

在東協，隨著都市區醫院在介入性心臟病學、心臟外科和影像學方面能力的提升，心臟瓣膜修復和置換服務正逐步擴展，但先進醫療中心與資源匱乏的醫療體系之間在醫療服務獲取方面仍存在顯著差距。海灣合作理事會（GCC）國家的特點是集中投資於三級醫療，快速採用先進的心血管技術，並透過招募專家和建造高容量醫院基礎設施來擴展結構性心臟病計畫。在歐盟，醫療醫療設備法規、臨床證據要求、醫療技術評估和國家醫保報銷流程的協調統一正在影響經導管和外科瓣膜治療技術的引入和應用。在金磚國家，大規模的病患群體和心血管疾病檢出率的提高，以及採購體系、國內生產政策、專家資源和經濟能力等方面的差異，導致了各種機會和挑戰。儘管七國集團（G7）國家普遍擁有先進的臨床技術、完善的指南實施、健全的上市後監測以及廣泛的複雜瓣膜治療，但醫療保健系統面臨的成本壓力仍然影響著技術評估。北約成員國與先進的北美和歐洲醫療保健系統高度重合，在這些地區，穩健的醫療供應鏈、醫院的緊急準備以及可互通的臨床數據基礎設施對於維持關鍵心血管醫療設備的可及性至關重要。

主要國家心臟瓣膜修復和置換術的趨勢

在美國，已建立完善的結構性心臟疾病診療體系，在經導管瓣膜治療方面擁有豐富的經驗，並積極利用註冊登記數據追蹤治療結果。在加拿大，重點在於公共資金支持的醫療服務、區域心臟中心以及循證先進瓣膜治療的引入。在墨西哥，瓣膜治療正在主要大都會圈的醫院中推廣，但其可近性因公立和私立醫療保健體系的差異以及專科醫生的集中程度而異。巴西擁有世界一流的循環系統中心，儘管對外科手術和經導管治療的需求都非常高，但成本效益和公共保險報銷仍然是影響治療方案採納的重要因素。在英國，瓣膜性心臟病的管理依賴於集中化的專科醫療服務、國家臨床指南和結構化的傳播管道。德國的特點是擁有先進的手術技術、完善的醫院基礎設施以及廣泛應用基於導管的瓣膜性心臟病治療技術。法國則將強大的循環系統臨床網路與嚴格的報銷體系和醫療技術評估流程結合。在俄羅斯，針對複雜瓣膜性心臟病的專科心臟中心已相當完善，但區域資源差異和地理因素影響著病患的就醫途徑。義大利和西班牙在心臟外科和介入性心臟病學方面擁有成熟的醫療能力，但其運作依賴當地醫療機構和公共醫療系統的資金籌措。中國正透過醫院投資、臨床醫師培訓和國內技術研發，迅速提升其治療結構性心臟疾病的能力。在印度，心臟中心正在擴大，未接受治療的瓣膜性心臟病患者數量眾多，但成本效益和早期診斷仍然是重要的挑戰。日本在治療老齡化性主動脈瓣狹窄、嚴格的監管實施和高標準的醫療操作方面表現卓越。澳洲擁有完善的心臟醫療網路和基於指南的瓣膜介入治療項目，而韓國則結合了先進的醫院系統、影像技術和日益成長的經導管結構性心臟病手術經驗。

心臟瓣膜裝置產業領導者使用的實用建議

產業領導企業應優先考慮具有臨床差異化的創新，以滿足二尖瓣和三尖瓣疾病、瓣膜耐久性、更小的輸送體積、減少瓣週漏以及為解剖結構複雜的患者提供治療方案等方面的未滿足需求。產品開發應基於可靠的臨床證據、透明的終點報告以及跨年齡層、合併症情況和手術風險類別的真實世界表現追蹤。各機構應投資於醫生培訓、基於模擬的教育、指導項目以及多學科心臟團隊的能力建設，以提高手術的一致性。醫院合作應專注於整合治療路徑，以加速診斷、就診、影像檢查、手術安排和長期追蹤。數位化和人工智慧能力的開發需要建立嚴格的檢驗方案、符合監管要求、網路安全措施以及明確的臨床課責。領導者還需要增強其植入式器械、輸送系統、影像附件和無菌組件價值鏈的韌性。在新興地區，進入策略應包括分階段培訓、服務模式調整、合作資金籌措以及支持醫療中心追求卓越。在所有市場中，競爭優勢很可能越來越取決於可衡量的患者療效、易用性、瓣膜的終身管理以及對醫療保健系統的價值證明。

基於證據調查方法

本執行摘要基於一套系統的調查方法，該方法結合了二手研究、臨床指南審查、監管資訊、同行評審文獻評估、公共衛生數據解讀以及專家對心血管器械發展趨勢的分析。所考慮的資訊來源包括國際和國家循環系統指南、瓣膜性心臟病和結構性心臟介入治療方面的科學期刊、監管安全資訊、臨床實驗室註冊數據、醫院診療模式、疾病負擔研究以及公開的醫療保健系統資訊。本分析著重於已驗證的質性研究結果和檢驗見解，而非推測性預測、市場規模估算或佔有率假設。透過評估醫療保健基礎設施、報銷趨勢、專科醫生資源、疾病負擔、手術應用、法規環境和就醫障礙，得出區域、群體和國家層面的具體見解。每個章節的編寫都旨在提高「心臟瓣膜修復裝置」、「心臟瓣膜置換裝置」、「經導管瓣膜治療」、「結構性心臟疾病」、「主動脈瓣置換術」、「二尖瓣修復」、「三尖瓣介入治療」和「微創心臟裝置」等術語的搜尋可見性，同時保持搜尋相關性和易於理解，以便於管理。

關於心臟瓣膜修復和置換裝置未來發展的結論

隨著結構性心臟疾病治療朝著更精準、微創和數據驅動的方向發展，心臟瓣膜修復和置換器材也在快速進步。其中，經導管介入治療、影像技術的更完善整合、人工智慧驅動的決策支援工具以及能夠根據患者解剖特徵和終身治療目標選擇合適器械的多學科診療模式，發展勢頭最為強勁。然而，區域普及程度仍取決於醫療基礎設施、報銷系統、專科醫生培訓以及能否獲得先進的影像技術和專業的心臟醫療中心。那些能夠將具有臨床意義的創新與嚴謹的循證醫學、負責任的數位整合、全面的培訓以及可擴展的准入策略相結合的行業領導者，將更有能力支持瓣膜性心臟病管理的下一階段發展。隨著治療管道的不斷發展，該領域的長期價值將體現在更安全的手術、更持久的治療效果、更少的併發症以及瓣膜性心臟病患者生活品質的提升。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：心臟瓣膜修復與置換器材市場：依產品類型

  • 維修裝置
    • 瓣環成形術
      • 手術環/帶
      • 經導管環瓣環成形術
    • 球囊瓣環成形/瓣膜葉片切開術
    • 索狀韌帶修復
    • 傳單修復
    • 閥門洩漏關閉
    • 經導管緣對緣修復術（TEER）
      • 二尖瓣TER
      • 三尖瓣TEER
  • 更換閥門
    • 再次手術方案
      • 閥門輸入 MAC
      • 閥門入口
      • 閥中閥
    • 外科瓣膜置換術
      • 生物瓣膜
      • 附支架
      • 防鏽的
      • 無需縫合/快速部署型
      • 機械閥
    • 經導管瓣膜置換術
      • 主動脈瓣（TAVR）
      • 二尖瓣（TMVR）
      • 肺動脈（TPVR）
      • 三尖瓣（TTVR）

第8章：心臟瓣膜修復和置換器械市場：按組件分類

  • 配件
    • 栓塞預防裝置
    • 成像導管
    • 導引器/鞘套
    • 可轉向導軌
  • 配送系統
  • 植入

第9章：心臟瓣膜修復與置換器械市場：依最終用戶分類

  • 門診手術中心
  • 心臟導管檢查室
  • 醫院
    • 區域醫院/二級醫療機構
    • 三級和四級醫療中心
  • 專業心臟病中心

第10章：心臟瓣膜修復與置換器械市場：按分銷管道分類

  • 離線
  • 線上

第11章：心臟瓣膜修復與置換器械市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：心臟瓣膜修復與置換器械市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：心臟瓣膜修復和置換器械市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Abbott Laboratories
  • Affluent Medical
  • Anteris Technologies Ltd
  • Artivion Inc
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cardiac Dimensions Inc
  • Cardiovalve Ltd
  • Colibri Heart Valve LLC
  • Comed BV
  • Edwards Lifesciences Corporation
  • Foldax Inc
  • HighLife Medical
  • Innovalve Bio Medical
  • JenaValve Technology Inc
  • Labcor Laboratorios Ltda
  • Lepu Medical Technology Beijing Co Ltd
  • LivaNova PLC
  • Medtronic plc
  • Meril Life Sciences Private Limited
  • Micro Interventional Devices Inc
  • MicroPort Scientific Corporation
  • Peijia Medical Technologies
  • TTK Healthcare Limited
  • Valcare Medical
  • Venus Medtech Hangzhou Inc
  • Xeltis NV
Product Code: MRR-925E8149CC89

The Heart Valve Repair & Replacement Devices Market is projected to grow by USD 12.70 billion at a CAGR of 8.43% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.20 billion
Estimated Year [2026] USD 7.80 billion
Forecast Year [2032] USD 12.70 billion
CAGR (%) 8.43%

Heart valve repair and replacement devices are central to the modern treatment of valvular heart disease, including aortic stenosis, mitral regurgitation, tricuspid valve disease, and congenital valve abnormalities. Demand is being shaped by aging populations, rising detection of structural heart disease, and the clinical shift toward less invasive cardiovascular interventions. Device categories span mechanical valves, bioprosthetic valves, transcatheter aortic valve replacement systems, transcatheter mitral and tricuspid repair technologies, annuloplasty rings, chordal repair systems, occluders, and adjunctive delivery platforms. Clinical decision-making is increasingly guided by multidisciplinary heart teams that assess anatomy, surgical risk, durability requirements, anticoagulation needs, quality-of-life goals, and long-term reintervention considerations. The sector is also influenced by evolving guidelines that support broader use of transcatheter procedures in selected patient populations, as well as growing attention to lifetime valve management. As hospitals strengthen structural heart programs, the competitive focus is moving beyond device implantation toward procedural planning, imaging integration, operator training, post-procedure surveillance, and patient-centered outcomes.

Transformative Shifts in the Heart Valve Device Landscape

The heart valve repair and replacement devices landscape is undergoing a major transformation as treatment pathways move from conventional open-heart surgery toward catheter-based, hybrid, and minimally invasive approaches. Transcatheter aortic valve replacement has become an established option for many patients with severe symptomatic aortic stenosis, while mitral and tricuspid interventions are advancing through improved device anchoring, leaflet approximation, annular remodeling, and valve-in-valve techniques. Imaging is a core enabler of this shift, with echocardiography, computed tomography, fluoroscopy, and fusion imaging supporting patient selection, procedural navigation, and complication mitigation. Another important transition is the growing emphasis on valve durability, hemodynamic performance, thrombosis prevention, paravalvular leak reduction, and treatment of younger or lower-risk patients where long-term outcomes are especially important. Regulatory scrutiny, post-market evidence requirements, and real-world registries are also reshaping product development by prioritizing safety, clinical endpoints, and reproducibility across diverse care settings. At the same time, hospitals are redesigning cardiac service lines around dedicated structural heart teams, streamlined referral networks, and standardized care pathways that reduce delays between diagnosis and intervention.

Cumulative Impact of Artificial Intelligence on Valve Care

Artificial intelligence is becoming a cumulative force across the heart valve repair and replacement device ecosystem, particularly in diagnosis, procedural planning, workflow optimization, and longitudinal monitoring. AI-enabled imaging tools can assist clinicians in segmenting valve anatomy, quantifying calcification, assessing annular dimensions, evaluating regurgitation severity, and identifying anatomical suitability for transcatheter procedures. Predictive analytics may support heart teams by integrating echocardiographic findings, CT measurements, comorbidities, frailty indicators, laboratory values, and prior interventions to refine procedural risk stratification. In procedural environments, AI-supported image guidance and automation can improve consistency in device sizing, access planning, and deployment simulation, while digital twins and computational modeling are being explored to anticipate hemodynamic outcomes and device-tissue interaction. After intervention, connected monitoring and algorithmic analysis can help identify arrhythmias, valve dysfunction, thrombotic risk, heart failure decompensation, and the need for follow-up imaging. The growing use of AI also introduces governance priorities around clinical validation, bias reduction, data interoperability, cybersecurity, explainability, and responsible integration into physician-led decision-making.

Key Regional Insights Across Global Valve Device Adoption

In Asia-Pacific, high procedure demand is supported by population aging, expanding cardiac imaging capacity, and increasing investment in tertiary cardiovascular centers, with China, Japan, India, South Korea, and Australia playing prominent roles in structural heart adoption. North America remains highly advanced in transcatheter valve procedures, multidisciplinary heart team adoption, reimbursement infrastructure, and real-world evidence generation, with strong emphasis on guideline-aligned care and post-approval safety monitoring. Latin America is progressing through increased specialization in major urban cardiac centers, although access can vary by payer structure, procedural cost, specialist availability, and public-sector capacity. Europe benefits from mature cardiovascular clinical networks, established device regulatory oversight, and broad expertise in both surgical valve replacement and catheter-based interventions, while national reimbursement policies influence adoption timing across countries. The Middle East is strengthening advanced cardiac care through specialized hospitals, medical tourism hubs, and investment in minimally invasive cardiovascular capabilities, especially in higher-income health systems. Across Africa, access to heart valve repair and replacement devices remains uneven, shaped by rheumatic heart disease burden, limited cardiac surgery infrastructure in many settings, workforce constraints, and reliance on regional centers of excellence for complex interventions.

Key Group Insights Across Economic and Strategic Alliances

ASEAN countries are experiencing gradual expansion of heart valve repair and replacement services as urban hospitals strengthen interventional cardiology, cardiac surgery, and diagnostic imaging capabilities, though access differs substantially between advanced medical hubs and resource-constrained health systems. The GCC is characterized by concentrated investment in tertiary care, rapid adoption of advanced cardiovascular technologies, and growing structural heart programs supported by specialist recruitment and high-capacity hospital infrastructure. Within the European Union, harmonized device regulation, clinical evidence requirements, health technology assessment, and national reimbursement pathways shape the introduction and utilization of transcatheter and surgical valve technologies. BRICS economies present diverse opportunities and constraints, combining large patient populations and rising cardiovascular disease detection with differences in procurement systems, domestic manufacturing policy, specialist availability, and affordability. G7 countries generally demonstrate high clinical sophistication, strong guideline implementation, robust post-market surveillance, and broad access to complex valve procedures, although health system cost pressures continue to influence technology assessment. NATO member countries overlap significantly with advanced North American and European health systems, where resilient medical supply chains, hospital readiness, and interoperable clinical data infrastructure are increasingly important for maintaining access to critical cardiovascular devices.

Key Country Insights in Heart Valve Repair & Replacement

The United States has extensive structural heart programs, broad experience with transcatheter valve therapies, and strong use of registry-based evidence to track outcomes. Canada emphasizes publicly funded access, regional cardiac centers, and evidence-based adoption of advanced valve interventions. Mexico is expanding valve care in major metropolitan hospitals, with access influenced by public-private care differences and specialist concentration. Brazil has leading cardiovascular centers and a substantial need for both surgical and transcatheter solutions, while affordability and public reimbursement remain important adoption factors. The United Kingdom relies on centralized specialist services, national clinical guidance, and structured referral pathways for valve disease management. Germany has a high level of procedural expertise, advanced hospital infrastructure, and broad use of catheter-based valve technologies. France combines strong cardiovascular clinical networks with rigorous reimbursement and health technology assessment processes. Russia has developed specialist cardiac centers for complex valve disease, although geography and regional resource variation influence patient access. Italy and Spain maintain established cardiac surgery and interventional cardiology capabilities, with adoption shaped by regional healthcare organization and public system funding. China is scaling structural heart capacity rapidly through investment in hospitals, clinician training, and domestic technology development. India has expanding cardiac centers and a large untreated valve disease population, with affordability and early diagnosis remaining critical. Japan is advanced in aging-related aortic stenosis care, careful regulatory adoption, and high procedural quality standards. Australia has strong cardiac networks and guideline-driven valve intervention programs, while South Korea combines advanced hospital systems, imaging capabilities, and growing expertise in transcatheter structural heart procedures.

Actionable Recommendations for Heart Valve Device Leaders

Industry leaders should prioritize clinically differentiated innovation that addresses unmet needs in mitral and tricuspid disease, valve durability, smaller delivery profiles, paravalvular leak mitigation, and treatment options for anatomically complex patients. Product development should be anchored in robust clinical evidence, transparent endpoint reporting, and real-world performance tracking across age groups, comorbidity profiles, and procedural risk categories. Organizations should invest in physician training, simulation-based education, proctoring models, and multidisciplinary heart team enablement to improve procedural consistency. Partnerships with hospitals should focus on integrated pathways that accelerate diagnosis, referral, imaging review, procedure scheduling, and long-term follow-up. Digital and AI capabilities should be developed with strong validation protocols, regulatory alignment, cybersecurity safeguards, and clear clinical accountability. Leaders should also strengthen supply chain resilience for implantable devices, delivery systems, imaging-compatible accessories, and sterile components. In emerging regions, access strategies should include tiered training, service model adaptation, financing collaboration, and support for centers of excellence. Across all markets, competitive advantage will increasingly depend on measurable patient outcomes, ease of use, lifetime valve management, and evidence of value for health systems.

Research Methodology for Evidence-Based Valve Device Insights

This executive summary is based on a structured research methodology that combines secondary research, clinical guideline review, regulatory intelligence, peer-reviewed literature assessment, public health data interpretation, and expert-level synthesis of cardiovascular device trends. Sources considered include international and national cardiology guidelines, scientific publications on valvular heart disease and structural heart interventions, regulatory safety communications, clinical trial registries, hospital practice patterns, disease burden studies, and publicly available health system information. The analysis emphasizes verified qualitative and evidence-backed insights rather than speculative projections, market sizing, or share-based assumptions. Regional, group, and country insights were developed by evaluating healthcare infrastructure, reimbursement dynamics, specialist availability, disease burden, procedural adoption maturity, regulatory environments, and access barriers. Each section was written to support search visibility for terms such as heart valve repair devices, heart valve replacement devices, transcatheter valve therapy, structural heart disease, aortic valve replacement, mitral valve repair, tricuspid valve intervention, and minimally invasive cardiac devices, while maintaining clinical relevance and executive readability.

Conclusion on the Future of Heart Valve Repair & Replacement Devices

Heart valve repair and replacement devices are advancing rapidly as structural heart care becomes more precise, less invasive, and increasingly data-driven. The strongest momentum is seen in transcatheter approaches, improved imaging integration, AI-supported decision tools, and multidisciplinary care models that align device selection with patient anatomy and lifetime treatment goals. Regional adoption remains shaped by healthcare infrastructure, reimbursement systems, specialist training, and access to advanced imaging and cardiac centers. Industry leaders that combine clinically meaningful innovation with rigorous evidence generation, responsible digital integration, robust training, and scalable access strategies will be best positioned to support the next phase of valve disease management. As care pathways continue to evolve, the sector's long-term value will be defined by safer procedures, durable outcomes, reduced complications, and improved quality of life for patients living with valvular heart disease.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Heart Valve Repair & Replacement Devices Market, by Product Category

  • 7.1. Introduction
  • 7.2. Repair Devices
    • 7.2.1. Annuloplasty
      • 7.2.1.1. Surgical Rings/Bands
      • 7.2.1.2. Transcatheter Annuloplasty
    • 7.2.2. Balloon Valvuloplasty/Commissurotomy
    • 7.2.3. Chordal Repair
    • 7.2.4. Leaflet Repair
    • 7.2.5. Paravalvular Leak Closure
    • 7.2.6. Transcatheter Edge-To-Edge Repair (TEER)
      • 7.2.6.1. Mitral TEER
      • 7.2.6.2. Tricuspid TEER
  • 7.3. Replacement Valves
    • 7.3.1. Redo Solutions
      • 7.3.1.1. Valve-In-MAC
      • 7.3.1.2. Valve-In-Ring
      • 7.3.1.3. Valve-In-Valve
    • 7.3.2. Surgical Valve Replacement
      • 7.3.2.1. Bioprosthetic Valves
      • 7.3.2.1.1. Stented
      • 7.3.2.1.2. Stentless
      • 7.3.2.1.3. Sutureless/Rapid-Deployment
      • 7.3.2.2. Mechanical Valves
    • 7.3.3. Transcatheter Valve Replacement
      • 7.3.3.1. Aortic (TAVR)
      • 7.3.3.2. Mitral (TMVR)
      • 7.3.3.3. Pulmonary (TPVR)
      • 7.3.3.4. Tricuspid (TTVR)

8. Heart Valve Repair & Replacement Devices Market, by Component

  • 8.1. Introduction
  • 8.2. Accessories
    • 8.2.1. Embolic Protection Devices
    • 8.2.2. Imaging Catheters
    • 8.2.3. Introducers/Sheaths
    • 8.2.4. Steerable Guides
  • 8.3. Delivery System
  • 8.4. Implant

9. Heart Valve Repair & Replacement Devices Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Cardiac Catheterization Labs
  • 9.4. Hospitals
    • 9.4.1. Community/Secondary Hospitals
    • 9.4.2. Tertiary/Quaternary Centers
  • 9.5. Specialty Heart Centers

10. Heart Valve Repair & Replacement Devices Market, by Sales Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Heart Valve Repair & Replacement Devices Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Heart Valve Repair & Replacement Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Heart Valve Repair & Replacement Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. FPNV Positioning Matrix, 2025
  • 14.3. Market Concentration Analysis, 2025
    • 14.3.1. Concentration Ratio (CR)
    • 14.3.2. Herfindahl Hirschman Index (HHI)
  • 14.4. Recent Developments & Impact Analysis, 2025
  • 14.5. Product Portfolio Analysis, 2025
  • 14.6. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Abbott Laboratories
  • 15.2. Affluent Medical
  • 15.3. Anteris Technologies Ltd
  • 15.4. Artivion Inc
  • 15.5. Boston Scientific Corporation
  • 15.6. Braile Biomedica
  • 15.7. Cardiac Dimensions Inc
  • 15.8. Cardiovalve Ltd
  • 15.9. Colibri Heart Valve LLC
  • 15.10. Comed BV
  • 15.11. Edwards Lifesciences Corporation
  • 15.12. Foldax Inc
  • 15.13. HighLife Medical
  • 15.14. Innovalve Bio Medical
  • 15.15. JenaValve Technology Inc
  • 15.16. Labcor Laboratorios Ltda
  • 15.17. Lepu Medical Technology Beijing Co Ltd
  • 15.18. LivaNova PLC
  • 15.19. Medtronic plc
  • 15.20. Meril Life Sciences Private Limited
  • 15.21. Micro Interventional Devices Inc
  • 15.22. MicroPort Scientific Corporation
  • 15.23. Peijia Medical Technologies
  • 15.24. TTK Healthcare Limited
  • 15.25. Valcare Medical
  • 15.26. Venus Medtech Hangzhou Inc
  • 15.27. Xeltis NV

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 21. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL REPAIR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL REPAIR DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL REPAIR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANNULOPLASTY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANNULOPLASTY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANNULOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL RINGS/BANDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL RINGS/BANDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL RINGS/BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TRANSCATHETER ANNULOPLASTY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TRANSCATHETER ANNULOPLASTY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TRANSCATHETER ANNULOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BALLOON VALVULOPLASTY/COMMISSUROTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BALLOON VALVULOPLASTY/COMMISSUROTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BALLOON VALVULOPLASTY/COMMISSUROTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CHORDAL REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CHORDAL REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CHORDAL REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LEAFLET REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LEAFLET REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LEAFLET REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PARAVALVULAR LEAK CLOSURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PARAVALVULAR LEAK CLOSURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PARAVALVULAR LEAK CLOSURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MITRAL TEER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MITRAL TEER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MITRAL TEER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TRICUSPID TEER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TRICUSPID TEER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TRICUSPID TEER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL REPLACEMENT VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL REPLACEMENT VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL REPLACEMENT VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL REDO SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL REDO SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL REDO SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VALVE-IN-MAC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VALVE-IN-MAC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VALVE-IN-MAC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VALVE-IN-RING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VALVE-IN-RING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VALVE-IN-RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VALVE-IN-VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VALVE-IN-VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VALVE-IN-VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL VALVE REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL VALVE REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL VALVE REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOPROSTHETIC VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOPROSTHETIC VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOPROSTHETIC VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL STENTED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL STENTED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL STENTED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL STENTLESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL STENTLESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL STENTLESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SUTURELESS/RAPID-DEPLOYMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SUTURELESS/RAPID-DEPLOYMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SUTURELESS/RAPID-DEPLOYMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MECHANICAL VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MECHANICAL VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MECHANICAL VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL TRANSCATHETER VALVE REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL TRANSCATHETER VALVE REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL TRANSCATHETER VALVE REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AORTIC (TAVR) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AORTIC (TAVR) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AORTIC (TAVR) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MITRAL (TMVR) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MITRAL (TMVR) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MITRAL (TMVR) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PULMONARY (TPVR) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PULMONARY (TPVR) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PULMONARY (TPVR) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL TRICUSPID (TTVR) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL TRICUSPID (TTVR) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL TRICUSPID (TTVR) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ACCESSORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ACCESSORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL IMAGING CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL IMAGING CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL IMAGING CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRODUCERS/SHEATHS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL INTRODUCERS/SHEATHS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRODUCERS/SHEATHS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL STEERABLE GUIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL STEERABLE GUIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL STEERABLE GUIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL IMPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL IMPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CARDIAC CATHETERIZATION LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CARDIAC CATHETERIZATION LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CARDIAC CATHETERIZATION LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL COMMUNITY/SECONDARY HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL COMMUNITY/SECONDARY HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL COMMUNITY/SECONDARY HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL TERTIARY/QUATERNARY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL TERTIARY/QUATERNARY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL TERTIARY/QUATERNARY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL SPECIALTY HEART CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL SPECIALTY HEART CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL SPECIALTY HEART CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 241. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 242. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 243. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 244. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 245. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 246. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 247. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 248. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 249. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 250. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 251. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 252. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 254. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 275. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 286. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 287. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 288. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 289. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 290. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 291. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 292. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 293. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 294. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 295. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 296. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 297. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 299. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 301. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 302. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 303. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 304. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 305. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 306. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 307. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 308. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 309. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 310. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 311. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 312. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES